SG Americas Securities’s Exact Sciences EXAS Stock Holding History

SG Americas Securities’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-35,000	Closed	-$24K	–	3356
2020 Q4	$24K	Hold	35,000	–	–	﹤0.01%	3195
2020 Q3	$326K	Buy	+35,000	New	+$3.02M	﹤0.01%	1887
2019 Q2	–	Sell	-10,000	Closed	-$34K	–	3181
2019 Q1	$34K	Buy	+10,000	New	+$851K	﹤0.01%	3243

Other funds holding EXAS

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

PRS

Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return

PWMAG

Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.46B AUM 22.77% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

SG Americas Securities's EXAS Position: Q1 2026 in Review

SG Americas Securities sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 414,874 shares — an estimated $42.1M sold.

SG Americas Securities first reported a position in EXAS in Q3 2013 and held it in 40 quarters. The position peaked at $42.1M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

SG Americas Securities reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
SG Americas Securities sold 414,874 Exact Sciences shares in Q1 2026, an estimated $42.1M.
SG Americas Securities first reported a position in Exact Sciences in Q3 2013 and held it in 40 quarters.
SG Americas Securities's Exact Sciences position peaked at $42.1M in Q4 2025.
7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on SG Americas Securities's 13F filing for Q1 2026, filed 16 Apr 2026.